Arcturus Therapeutics Holdings (ARCT) Return on Invested Capital (2023 - 2025)
Historic Return on Invested Capital for Arcturus Therapeutics Holdings (ARCT) over the last 3 years, with Q2 2025 value amounting to 0.31%.
- Arcturus Therapeutics Holdings' Return on Invested Capital rose 400.0% to 0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.31%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.37% for FY2024, which is 900.0% down from last year.
- According to the latest figures from Q2 2025, Arcturus Therapeutics Holdings' Return on Invested Capital is 0.31%, which was up 400.0% from 0.34% recorded in Q1 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Return on Invested Capital registered a high of 0.21% during Q3 2023, and its lowest value of 0.46% during Q1 2024.
- Its 3-year average for Return on Invested Capital is 0.28%, with a median of 0.33% in 2025.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Return on Invested Capital crashed by -5200bps in 2024 and then surged by 1200bps in 2025.
- Quarter analysis of 3 years shows Arcturus Therapeutics Holdings' Return on Invested Capital stood at 0.3% in 2023, then dropped by -28bps to 0.38% in 2024, then rose by 18bps to 0.31% in 2025.
- Its Return on Invested Capital stands at 0.31% for Q2 2025, versus 0.34% for Q1 2025 and 0.38% for Q4 2024.